home / stock / dsgn / dsgn short
Short Information | Design Therapeutics Inc. (NASDAQ:DSGN)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 422,915 |
Total Actual Volume | 3,612,093 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 21,146 |
Average Short Percentage | 11.73% |
Is there a DSGN Short Squeeze or Breakout about to happen?
See the DSGN Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-16-2024 | $4.58 | $4.55 | $4.705 | $4.44 | 213,116 | 12,165 | 5.71% |
07-15-2024 | $4.39 | $4.48 | $4.6 | $4.2993 | 143,881 | 4,729 | 3.29% |
07-12-2024 | $4.32 | $4.36 | $4.56 | $4.27 | 210,495 | 25,823 | 12.27% |
07-11-2024 | $3.74 | $4.24 | $4.29 | $3.66 | 205,900 | 37,997 | 18.45% |
07-10-2024 | $3.45 | $3.62 | $3.66 | $3.45 | 34,164 | 4,979 | 14.57% |
07-09-2024 | $3.49 | $3.5 | $3.54 | $3.42 | 58,044 | 2,296 | 3.96% |
07-08-2024 | $3.46 | $3.5 | $3.57 | $3.46 | 93,881 | 4,748 | 5.06% |
07-05-2024 | $3.17 | $3.42 | $3.44 | $3.15 | 77,061 | 8,535 | 11.08% |
07-03-2024 | $3.23 | $3.19 | $3.33 | $3.16 | 417,876 | 48,681 | 11.65% |
07-02-2024 | $3.25 | $3.2 | $3.4 | $3.17 | 151,139 | 24,510 | 16.22% |
07-01-2024 | $3.32 | $3.25 | $3.35 | $3.21 | 166,612 | 35,378 | 21.23% |
06-28-2024 | $3.4 | $3.35 | $3.5 | $3.2375 | 397,800 | 32,217 | 8.1% |
06-27-2024 | $3.25 | $3.35 | $3.38 | $3.21 | 167,072 | 16,259 | 9.73% |
06-26-2024 | $3.29 | $3.23 | $3.31 | $3.1695 | 145,840 | 20,505 | 14.06% |
06-25-2024 | $3.32 | $3.31 | $3.43 | $3.29 | 182,491 | 27,824 | 15.25% |
06-24-2024 | $3.37 | $3.36 | $3.43 | $3.295 | 193,475 | 12,367 | 6.39% |
06-21-2024 | $3.32 | $3.38 | $3.42 | $3.32 | 183,126 | 13,197 | 7.21% |
06-20-2024 | $3.57 | $3.31 | $3.61 | $3.3 | 240,281 | 24,771 | 10.31% |
06-18-2024 | $3.82 | $3.54 | $3.84 | $3.53 | 165,010 | 19,230 | 11.65% |
06-17-2024 | $3.69 | $3.82 | $3.83 | $3.6858 | 164,829 | 46,704 | 28.33% |
News, Short Squeeze, Breakout and More Instantly...
Design Therapeutics Inc. Company Name:
DSGN Stock Symbol:
NASDAQ Market:
Design Therapeutics Inc. Website:
Advancing DT-216P2, New Drug Product for Friedreich Ataxia (FA), Toward Clinical Trials Starting Phase 1 Development for Fuchs Endothelial Corneal Dystrophy (FECD) in 2024; Observational Study Currently Enrolling Patients Progressing GeneTAC TM Pipeline Programs in H...
CARLSBAD, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a biotechnology company developing treatments for serious degenerative genetic diseases, today announced that management will participate in a fireside chat at the 2024 RBC Capital Markets Healthcare Conf...
New Drug Product for Friedreich Ataxia (FA) DT-216P2 with Favorable Nonclinical Pharmacokinetic and Injection Site Safety Profile; Complete GLP Studies by Year-end 2024 to Start Patient Trials in 2025 IND Cleared for DT-168 for Treatment of Fuchs Endothelial Corneal Dystrophy (FECD) wit...